サマリー

免疫診断薬の世界市場 2023-2027 年
免疫診断薬市場は、2022年から2027年の間に22669.75百万米ドルで成長し、予測期間中のCAGRは12%で加速すると予測されます。当レポートでは、免疫診断薬市場の全体的な分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25のベンダーをカバーするベンダー分析などを掲載しています。
現在の市場シナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、バイオマーカーベースの検査に対する需要の増加、免疫診断学の技術の進歩、老年人口の増加によって牽引されています。
Technavioの免疫診断薬市場は以下のように区分されます：
製品別
- 試薬・消耗品
- 免疫診断システム
アプリケーション別
- 腫瘍学・内分泌学
- 肝炎・レトロウイルス
- 感染症
- 腸管便
- その他のアプリケーション
地域別状況
- 北アメリカ
- ヨーロッパ
- アジア
- その他の地域(ROW)
本調査では、個別化医療に対する需要の高まりが、今後数年間における免疫診断薬市場の成長を促進する主要な理由の1つであることを明らかにしています。また、ポイントオブケア検査（POCT）の出現と自動化システムに対する需要の高まりが、市場の大きな需要につながると考えられます。
本レポートでは、免疫診断薬市場について、以下の分野を取り上げています：
- 免疫診断薬市場のサイジング
- 免疫診断薬市場の予測
- 免疫診断薬市場の業界分析
本レポートでは、免疫診断薬市場の主要ベンダー（Abbott Laboratories、Adaptive Biotechnologies Corp.、AESKU.GROUP GmbH and Co.KG、bioMerieux SA、Danaher Corp.、Exagen Inc.、F.Hoffmann La Roche Ltd.、HUMAN Gesellschaft fur Biochemica und Diagnostica mbH、Nexus Dx Inc、Omega Diagnostics Group Plc、QuidelOrtho Corp、Seramun Diagnostica GmbH、Siemens AG、SQI Diagnostics Inc、Sysmex Corp、Thermo Fisher Scientific Inc、Werfenlife SA、Tecan Trading AG、OraSure Technologies Inc、及びDiaSorin SpAなど。また、免疫診断薬市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、以下をご覧ください - https://www.technavio.com/report/immunodiagnostics-market-industry-analysis
本書は、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数のソースからのデータを調査、合成、要約することにより、市場の詳細なイメージを提示します。業界の主要なインフルエンサーを特定することにより、様々な市場の様相を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。市場調査レポートでは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた詳細なベンダー選択方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global immunodiagnostics market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global immunodiagnostics market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Reagents and consumables - Market size and forecast 2022-2027
o Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
o 6.4 Immunodiagnostic systems - Market size and forecast 2022-2027
o Exhibit 38: Chart on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application - Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Oncology and endocrinology - Market size and forecast 2022-2027
o Exhibit 48: Chart on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
o 7.4 Hepatitis and retrovirus - Market size and forecast 2022-2027
o Exhibit 52: Chart on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
o 7.5 Infectious disease - Market size and forecast 2022-2027
o Exhibit 56: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
o 7.6 GI stool - Market size and forecast 2022-2027
o Exhibit 60: Chart on GI stool - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on GI stool - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on GI stool - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on GI stool - Year-over-year growth 2022-2027 (%)
o 7.7 Other applications - Market size and forecast 2022-2027
o Exhibit 64: Chart on Other applications - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Data Table on Other applications - Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Chart on Other applications - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Other applications - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Application
o Exhibit 68: Market opportunity by Application ($ million)
o Exhibit 69: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 73: Chart on Geographic comparison
o Exhibit 74: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 Canada - Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 111: Market opportunity By Geographical Landscape ($ million)
o Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 113: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 115: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 116: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 117: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 118: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 119: Abbott Laboratories - Overview
o Exhibit 120: Abbott Laboratories - Business segments
o Exhibit 121: Abbott Laboratories - Key news
o Exhibit 122: Abbott Laboratories - Key offerings
o Exhibit 123: Abbott Laboratories - Segment focus
o 12.4 Adaptive Biotechnologies Corp.
o Exhibit 124: Adaptive Biotechnologies Corp. - Overview
o Exhibit 125: Adaptive Biotechnologies Corp. - Product / Service
o Exhibit 126: Adaptive Biotechnologies Corp. - Key offerings
o 12.5 AESKU.GROUP GmbH and Co. KG
o Exhibit 127: AESKU.GROUP GmbH and Co. KG - Overview
o Exhibit 128: AESKU.GROUP GmbH and Co. KG - Product / Service
o Exhibit 129: AESKU.GROUP GmbH and Co. KG - Key offerings
o 12.6 bioMerieux SA
o Exhibit 130: bioMerieux SA - Overview
o Exhibit 131: bioMerieux SA - Product / Service
o Exhibit 132: bioMerieux SA - Key offerings
o 12.7 Danaher Corp.
o Exhibit 133: Danaher Corp. - Overview
o Exhibit 134: Danaher Corp. - Business segments
o Exhibit 135: Danaher Corp. - Key news
o Exhibit 136: Danaher Corp. - Key offerings
o Exhibit 137: Danaher Corp. - Segment focus
o 12.8 DiaSorin SpA
o Exhibit 138: DiaSorin SpA - Overview
o Exhibit 139: DiaSorin SpA - Business segments
o Exhibit 140: DiaSorin SpA - Key news
o Exhibit 141: DiaSorin SpA - Key offerings
o Exhibit 142: DiaSorin SpA - Segment focus
o 12.9 F. Hoffmann La Roche Ltd.
o Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
o 12.10 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
o Exhibit 148: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
o Exhibit 149: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
o Exhibit 150: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
o 12.11 OraSure Technologies Inc.
o Exhibit 151: OraSure Technologies Inc. - Overview
o Exhibit 152: OraSure Technologies Inc. - Business segments
o Exhibit 153: OraSure Technologies Inc. - Key offerings
o Exhibit 154: OraSure Technologies Inc. - Segment focus
o 12.12 QuidelOrtho Corp.
o Exhibit 155: QuidelOrtho Corp. - Overview
o Exhibit 156: QuidelOrtho Corp. - Product / Service
o Exhibit 157: QuidelOrtho Corp. - Key offerings
o 12.13 Siemens AG
o Exhibit 158: Siemens AG - Overview
o Exhibit 159: Siemens AG - Business segments
o Exhibit 160: Siemens AG - Key news
o Exhibit 161: Siemens AG - Key offerings
o Exhibit 162: Siemens AG - Segment focus
o 12.14 SQI Diagnostics Inc.
o Exhibit 163: SQI Diagnostics Inc. - Overview
o Exhibit 164: SQI Diagnostics Inc. - Product / Service
o Exhibit 165: SQI Diagnostics Inc. - Key offerings
o 12.15 Sysmex Corp.
o Exhibit 166: Sysmex Corp. - Overview
o Exhibit 167: Sysmex Corp. - Business segments
o Exhibit 168: Sysmex Corp. - Key offerings
o Exhibit 169: Sysmex Corp. - Segment focus
o 12.16 Tecan Trading AG
o Exhibit 170: Tecan Trading AG - Overview
o Exhibit 171: Tecan Trading AG - Business segments
o Exhibit 172: Tecan Trading AG - Key offerings
o Exhibit 173: Tecan Trading AG - Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 174: Thermo Fisher Scientific Inc. - Overview
o Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 176: Thermo Fisher Scientific Inc. - Key news
o Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 179: Inclusions checklist
o Exhibit 180: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 181: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 182: Research methodology
o Exhibit 183: Validation techniques employed for market sizing
o Exhibit 184: Information sources
o 13.5 List of abbreviations
o Exhibit 185: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global immunodiagnostics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product - Market share 2022-2027 (%)
Exhibits31: Data Table on Product - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Application - Market share 2022-2027 (%)
Exhibits45: Data Table on Application - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on GI stool - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on GI stool - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on GI stool - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibits65: Data Table on Other applications - Market size and forecast 2022-2027 ($ million)
Exhibits66: Chart on Other applications - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Other applications - Year-over-year growth 2022-2027 (%)
Exhibits68: Market opportunity by Application ($ million)
Exhibits69: Data Table on Market opportunity by Application ($ million)
Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits73: Chart on Geographic comparison
Exhibits74: Data Table on Geographic comparison
Exhibits75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits108: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits109: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits111: Market opportunity By Geographical Landscape ($ million)
Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits113: Impact of drivers and challenges in 2022 and 2027
Exhibits114: Overview on Criticality of inputs and Factors of differentiation
Exhibits115: Overview on factors of disruption
Exhibits116: Impact of key risks on business
Exhibits117: Vendors covered
Exhibits118: Matrix on vendor position and classification
Exhibits119: Abbott Laboratories - Overview
Exhibits120: Abbott Laboratories - Business segments
Exhibits121: Abbott Laboratories - Key news
Exhibits122: Abbott Laboratories - Key offerings
Exhibits123: Abbott Laboratories - Segment focus
Exhibits124: Adaptive Biotechnologies Corp. - Overview
Exhibits125: Adaptive Biotechnologies Corp. - Product / Service
Exhibits126: Adaptive Biotechnologies Corp. - Key offerings
Exhibits127: AESKU.GROUP GmbH and Co. KG - Overview
Exhibits128: AESKU.GROUP GmbH and Co. KG - Product / Service
Exhibits129: AESKU.GROUP GmbH and Co. KG - Key offerings
Exhibits130: bioMerieux SA - Overview
Exhibits131: bioMerieux SA - Product / Service
Exhibits132: bioMerieux SA - Key offerings
Exhibits133: Danaher Corp. - Overview
Exhibits134: Danaher Corp. - Business segments
Exhibits135: Danaher Corp. - Key news
Exhibits136: Danaher Corp. - Key offerings
Exhibits137: Danaher Corp. - Segment focus
Exhibits138: DiaSorin SpA - Overview
Exhibits139: DiaSorin SpA - Business segments
Exhibits140: DiaSorin SpA - Key news
Exhibits141: DiaSorin SpA - Key offerings
Exhibits142: DiaSorin SpA - Segment focus
Exhibits143: F. Hoffmann La Roche Ltd. - Overview
Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
Exhibits145: F. Hoffmann La Roche Ltd. - Key news
Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits148: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
Exhibits149: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
Exhibits150: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
Exhibits151: OraSure Technologies Inc. - Overview
Exhibits152: OraSure Technologies Inc. - Business segments
Exhibits153: OraSure Technologies Inc. - Key offerings
Exhibits154: OraSure Technologies Inc. - Segment focus
Exhibits155: QuidelOrtho Corp. - Overview
Exhibits156: QuidelOrtho Corp. - Product / Service
Exhibits157: QuidelOrtho Corp. - Key offerings
Exhibits158: Siemens AG - Overview
Exhibits159: Siemens AG - Business segments
Exhibits160: Siemens AG - Key news
Exhibits161: Siemens AG - Key offerings
Exhibits162: Siemens AG - Segment focus
Exhibits163: SQI Diagnostics Inc. - Overview
Exhibits164: SQI Diagnostics Inc. - Product / Service
Exhibits165: SQI Diagnostics Inc. - Key offerings
Exhibits166: Sysmex Corp. - Overview
Exhibits167: Sysmex Corp. - Business segments
Exhibits168: Sysmex Corp. - Key offerings
Exhibits169: Sysmex Corp. - Segment focus
Exhibits170: Tecan Trading AG - Overview
Exhibits171: Tecan Trading AG - Business segments
Exhibits172: Tecan Trading AG - Key offerings
Exhibits173: Tecan Trading AG - Segment focus
Exhibits174: Thermo Fisher Scientific Inc. - Overview
Exhibits175: Thermo Fisher Scientific Inc. - Business segments
Exhibits176: Thermo Fisher Scientific Inc. - Key news
Exhibits177: Thermo Fisher Scientific Inc. - Key offerings
Exhibits178: Thermo Fisher Scientific Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations